Self-stabilized oligonucleotides as therapeutic agents

Details Self-stabilized oligonucleotides as therapeutic agents Self-stabilized oligonucleotides as therapeutic agents

C - Chemistry, Metallurgy

12

N

C12N 15/11 (2006.01) A61K 31/70 (2006.01) C07H 21/00 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2139319

2139319 9401550 PCTABS00030 The invention provides improved antisense oligonucleotides that are resistant to nucleolytic degradation. Such oligonuclotides are called self-stabilized oligonucleotides and comprise two regions: a target hybridizing region having a nucleotide sequence complementary to a nucleic acid sequence that is from a virus, a pathogenic organism, or a cellular gene; and a self-complementary region having an oligonucleotide sequence complementary to a nucleic acid sequence that is within the self-stabilized oligonucleotide.

Affiliated with

Also associated with

Rating

Self-stabilized oligonucleotides as therapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Self-stabilized oligonucleotides as therapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Self-stabilized oligonucleotides as therapeutic agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1892648